Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VIKAS LIFECARE LIMITED Board/Management Information 2021

Jul 16, 2021

60454_rns_2021-07-16_8b7457a9-24eb-40c8-aa8f-b1bc45930e89.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [187 x 119] intentionally omitted <==

==> picture [211 x 119] intentionally omitted <==

==> picture [159 x 119] intentionally omitted <==

July 16, 2021

Listing Department Deptt of Corporate Se r vices National Stock Exchange of In d ia Limited BSE Limited Exchange Plaza Phirozee Jeejeebhoy T owers, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (E), Mumbai 400 051 Mumbai 400 001 NSE Symbol: VIKASLIFE Scrip Code: 542655

Sub: Intimation of Board Meeting to be held on July 19, 2021

Dear Sir/Madam,

In terms of Regulation 29 of t he SEBI (Listing Obligations and Disclosure R equirements) Regulations, 2015, we wish to inform you t hat the meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 19 , 2021at the Registered Office of the Compan y at G-1 34/1, East Punjabi Bagh, New Delhi - 110026, int e r-alia, to consider and approve the following :

  • i. review the status of c ompany’s ongoing debt reduction program, accelerate the process to achieve the status of z e ro debt company even before the decided d e adlines.

  • ii. review the report sub m itted by the Board Committee constituted f or pharma and healthcare business, status of ac q uisition of Advik Laboratories Limited, an d other matters connected therewith, incidental thereto.

  • iii. authorization to submit EOI (Expression of Interest) under Insolvency and Bankruptcy Code, 2016 (I&B Code) for r e solution of M/s Hydrolina Biotech Private Li m ited, (a company engaged in the business of Nu t raceuticals, Vitalinaa- Spirulina Products a n d having R&D Centre and Manufacturing Plant i n Tamilnadu) with NCLT (Chennai Branc h ), to further strengthen company's healthcare a nd pharmaceutical portfolio

  • iv. conceptualize and de v ise new corporate management structure/l a dder to professionally run the company, includi n g switching of executive positions held by p romoters to professionals, wherever necessary.

  • v. any other item(s) with the permission of the Chair.

You are requested to take the information on record and oblige. Yours Faithfully, for Vikas Lifecare Limited

==> picture [91 x 29] intentionally omitted <==

Vikas Garg Director DIN: 00255413

==> picture [191 x 38] intentionally omitted <==

==> picture [211 x 38] intentionally omitted <==

==> picture [161 x 38] intentionally omitted <==